Hak-sup Lee

Title: Innovations of Hak-sup Lee in Thrombopoietin Protein Variants

Introduction

Hak-sup Lee is a notable inventor based in Gangwon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of protein variants that have important biological functions. His work has implications for medical treatments and pharmaceutical applications.

Latest Patents

Hak-sup Lee holds a patent for "Thrombopoietin protein variants." This invention discloses a protein variant that substitutes valine for phenylalanine residue in a binding domain, which has a biological response-modifying function by binding to a receptor, ligand, or substrate. The patent also includes a DNA encoding the protein variant, a recombinant expression vector linked to the DNA, and a host cell that has been transformed or transfected with the vector. Furthermore, the invention outlines a method for preparing the protein variant by cultivating the host cell and isolating the protein from the resulting culture. Additionally, it presents a pharmaceutical composition that includes the protein variant and a pharmaceutically acceptable carrier.

Career Highlights

Hak-sup Lee is associated with Medexgen Co., Ltd., where he continues to advance his research and development efforts. His innovative work in protein variants has positioned him as a key figure in the biotechnology sector.

Collaborations

He has collaborated with notable colleagues, including Youn-Hwa Heo and Ki-Wan Yi, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Hak-sup Lee's contributions to the field of biotechnology, particularly through his patent on thrombopoietin protein variants, highlight his role as an influential inventor. His work not only advances scientific knowledge but also has the potential to impact medical treatments significantly.